An overview on Cytomegalovirus, its transmission modes, infection and disease. Also covered is CMV’s burden on solid organ transport, treatment strategies, viral load monitoring and the importance of standardization.

Impact of Molecular Diagnostic Testing on Hospital Acquired Infections

Jul 18th, 2012 29m 14s

Areas of discussion include Overview of nucleic acid amplification technologies, and Overview of Select Hospital Acquired Infections (Methicillin Resistant Staphylococcus Aureus, Vancomycin Resistant Enterococci, and Clostridium difficile).

Target Management of Women with Normal and ASC-US Cytology

Jul 18th, 2012 25m 11s

Overview of the ATHENA cervical cancer screening clinical trial, a 47,000 patient US registration study, by Dr. Warner Huh (gynecological oncologist). This presentation includes a review of the data for both normal and ASC-US cytology. It also

Human Papillomavirus: A Clinical Review

Jul 18th, 2012 18m 38s

An introduction to the Human Papillomavirus disease state including incidence and disease progression. The interrelationship of HPV to cervical cancer and the diagnostic applications to cervical cancer screening are also included.

MRSA Surveillance- Why Molecular

Jul 18th, 2012 2m 14s

Speedier results and greater sensitivity of molecular screening can better detect MRSA and prevent the spread of infection, with a good balance between infection control and treatment costs.

Chlamydia trachomatis and Neisseria gonorrhea: A Clinical Review

Jul 18th, 2012 18m 37s

An overview of CT/NG, including bacteriology and disease burden, infection epidemiology and diagnosis, screening guidelines, treatment, and prevention.

Leading the Pack with Molecular Diagnostic Testing for Cytomegalovirus (CMV)

Jul 18th, 2012 10m 28s

Areas of discussion include Epidemiology (Natural History; Mode of Transmission and Types of Infections), Virology of CMV (Characteristics of Cytomegalovirus (CMV), Replication and Viral Infection, and Disease syndromes), Molecular Detection of

AMP lify Your Knowledge of Group B Streptococcus (GBS)

Jul 18th, 2012 9m 23s

GBS infections are caused by the bacteria Streptococcus agalactiae. GBS can cause disease in newborns, pregnant women, the elderly, and adults with other medical conditions such as diabetes or liver disease. GBS is the most common cause of life

Group A Streptococcus: A clinical review (GAS)

Jul 18th, 2012 15m 53s

Areas of discussion include Overview of Group A streptococcus (GAS), Epidemiology of GAS, Clinical symptoms of GAS infections, Detection methods for GAS infections, and Treatment for GAS infections.Speaker: Art Braden, Ph.D., Roche Diagnostics

Leading the Pack with Hepatitis B Virus (HBV)

Jul 18th, 2012 24m 54s

Areas of discussion include Epidemiology and genotype (Natural History; Mode of Transmission and Types of Infections), Virology of HBV (Characteristics of the Hepatitis B Virus; Replication and Viral Infection), Molecular Detection of an HBV In

Leading the Pack with Human Immunodeficiency Virus (HIV)

Jul 18th, 2012 21m 58s

Areas of discussion include Epidemiology (Natural History; Mode of Transmission; Worldwide prevalence of HIV), Virology of HIV (Characteristics of HIV; HIV progression in clinical settings), Detection of HIV Infection (Rapid detection (screenin

MRSA Surveillance- Why Screen

Jul 18th, 2012 1m 51s

Professionals concerned about hospital infection control have innumerable questions about the need and efficacy of MRSA screening

MRSA Surveillance- Why Roche

Jul 18th, 2012 1m 32s

We asked infection control professionals what they wanted in a molecular screening test for MRSA. They said make it simple, flexible and reliable

AMP lify Your Knowledge of Methicillin Resistant Staphylococcus aureus (MRSA)

Jul 18th, 2012 17m 27s

A diversity of MRSA isolates are circulating in your local hospital and community. MRSA have sophisticated mechanisms for virulence in human hosts. Patients positive for MRSA must be isolated and treated aggressively to prevent secondary infect

Innovations In Molecular Diagnostics: VRE

Jul 18th, 2012 12m 2s

Microbial resistance to Vancomycin, once the antibiotic of last resort, highlights increasing concern with hospital acquired infections. Brought to you by Roche Molecular Diagnostics.

Leading the Pack with Hepatitis C Virus (HCV)

Jul 18th, 2012 27m 2s

Areas of discussion include Epidemiology (Natural History and Prevalence of HCV, Mode of Transmission, and Types of Infections), Virology of HCV (Characteristics of the Hepatitis C Virus (HCV), and Replication and Viral Infection), Diagnosis of

Leading the Pack with Herpes Simplex Virus (HSV)

Jul 18th, 2012 19m 50s

Areas of discussion include Biology of HSV Infection - Organism Characteristics, Epidemiological Information (HSV-1, and HSV-2), Pathogenesis (Modes of Transmission and Disease Progression), Diagnosis, Treatment Options, and Prevention Approach

Rate